Brigham and Women's Hospital-led research reports no significant long-term benefit of cocoa flavanol supplementation in ...

Dry age-related macular degeneration (AMD) significantly affects patients' daily activities and quality of life, regardless of visual impairment.

While young people aged 25-34 years old were the most likely to say an eye test is good value (72%), fewer than half actually ...

Macular degeneration and cataracts are two different eye conditions that have some shared symptoms, including blurriness and vision loss. The risk for both increases with age. Macular degeneration ...

As a result, it’s likely the woman – Denise Rodrigue, 68 – will never drive again. “She is recovering from a broken hip, has some cognitive issues, and macular degeneration,” defence lawyer John ...

Although it was only launched last year, the Kia EV3 has already made a big impact, most recently winning the UK Car of the Year Awards. When the South Korean brand first ventured into all ...

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved Encelto ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Encelto is the first FDA-approved treatment for ...

Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration. You may have vision loss that happens over time. Here’s what you can expect. With GA, you get blind spots in ...

ENCELTO is the first FDA-approved treatment for MacTel, utilizing encapsulated cell therapy to deliver CNTF to the retina. Neurotech’s ECT platform provides long-term delivery of therapeutic proteins ...

CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and ...